tirzepatide fatty liver disease A summary of the beneficial effects of across the spectrum Tirzepatide for MASH with Liver
Description
Taking into account that SGLT-2i and GLP-1RA are recommended as therapeutic alternatives by many clinical guidelines, usually as second-line treatments after first-line metformin, new users of SGLT-2i appear to be a suitable active comparator group

Srikanth Venugopalan They represented me for the 3M case

Each option works a little differently, and your provider will help determine the best fit based on your health history and goals

In this review, we discuss on vascular and metabolic effects of SGLT2i and GLP-1 in HF patients
During your visit, our physicians will recommend which makes the most sense based on your health profile and weight loss targets
